Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Cellcristin
2. Citomid
3. Farmistin
4. Leurocristine
5. Oncovin
6. Oncovine
7. Onkocristin
8. Pfs, Vincasar
9. Sulfate, Vincristine
10. Vincasar
11. Vincasar Pfs
12. Vincristin Bristol
13. Vincristin Medac
14. Vincristine
15. Vincrisul
16. Vintec
1. 2068-78-2
2. Kyocristine
3. Vincristine Sulphate
4. Vincrisul
5. Leurocristine Sulfate
6. Oncovin
7. Onkovin
8. Marqibo
9. 22-oxovincaleukoblastine Sulfate
10. Vcr Sulfate
11. Rel-vincristine Sulfate
12. Nsc 67574
13. Lilly 37231
14. Nsc67574
15. Nsc-67574
16. Leurocristine, Sulfate (1:1) (salt)
17. Alkaloid Extracted From Vinca Rosea Linn
18. Novopharm
19. Chebi:79401
20. 1217704-93-2
21. Mls002702994
22. Lilly-37231
23. Vincristini Sulfas
24. Oncovin (lilly)
25. Vincasar (tn)
26. Marqibo (tn)
27. Oncovin (tn)
28. Vincrex (tn)
29. Vincristine, Sulfate
30. Leurocristine, Sulfate
31. Vincristine Sulphate Salt
32. Vincristine Sulfate Liposome
33. Schembl3710
34. Leurocristine Sulfate (1:1)
35. Chembl501867
36. Dtxsid8044331
37. Vincristine Sulfate (jp17/usp)
38. Hms3414l13
39. Hms3678l11
40. Mfcd08706469
41. Akos015895862
42. V0129
43. Lcr
44. Vcr
45. D02197
46. 068v782
47. A936684
48. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((3s,5s,7s,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Sulfate
Molecular Weight | 923.0 g/mol |
---|---|
Molecular Formula | C46H58N4O14S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 10 |
Exact Mass | 922.36702371 g/mol |
Monoisotopic Mass | 922.36702371 g/mol |
Topological Polar Surface Area | 254 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 1830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
2 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
3 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
4 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-10-25
Pay. Date : 2021-10-21
DMF Number : 4932
Submission : 1983-06-01
Status : Active
Type : II
Certificate Number : R1-CEP 2004-048 - Rev 05
Issue Date : 2023-03-14
Type : Chemical
Substance Number : 749
Status : Valid
NDC Package Code : 69910-0003
Start Marketing Date : 2015-06-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4561
Submission : 1982-05-12
Status : Active
Type : II
Certificate Number : CEP 2021-387 - Rev 00
Issue Date : 2024-04-05
Type : Chemical
Substance Number : 749
Status : Valid
Registration Number : 306MF10067
Registrant's Address : 15 Hawkins Avenue, Epping 1,7460, Cape Town, South Africa
Initial Date of Registration : 2024-05-15
Latest Date of Registration : --
NDC Package Code : 48954-587
Start Marketing Date : 2016-08-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39943
Submission : 2024-09-15
Status : Active
Type : II
NDC Package Code : 62158-0010
Start Marketing Date : 2021-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3507
Submission : 1979-04-27
Status : Inactive
Type : II
Certificate Number : R1-CEP 1998-006 - Rev 03
Issue Date : 2008-09-17
Type : Chemical
Substance Number : 749
Status : Valid
Registration Number : 220MF10117
Registrant's Address : BUDAPEST, GYOMROI UT 19-21, HUNGARY
Initial Date of Registration : 2008-04-28
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4711
Submission : 1982-11-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4862
Submission : 1983-03-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12626
Submission : 1997-08-21
Status : Inactive
Type : II
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
GDUFA
DMF Review : Complete
Rev. Date : 2021-10-25
Pay. Date : 2021-10-21
DMF Number : 4932
Submission : 1983-06-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4561
Submission : 1982-05-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6500
Submission : 1986-07-28
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6290
Submission : 1986-04-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3507
Submission : 1979-04-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4711
Submission : 1982-11-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4862
Submission : 1983-03-30
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8400
Submission : 1990-01-26
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11285
Submission : 1995-01-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Date of Issue : 2022-11-09
Valid Till : 2025-08-08
Written Confirmation Number : WC-0138
Address of the Firm : Plot No. 285, 286 & 287, Bommasandra-Jigani Link Road, Industrial Area, KIADB, 4...
Vincristine Sulphate IP/BP/USP
Date of Issue : 2022-03-11
Valid Till : 2025-01-20
Written Confirmation Number : WC-0435
Address of the Firm : Plot No. T-6, M.I.D.C, Tarapur Industrial Area, Boisar, Dist- Thane - 401506 Mah...
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
NDC Package Code : 69910-0003
Start Marketing Date : 2015-06-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48954-587
Start Marketing Date : 2016-08-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7505
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (210g/210g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62158-0010
Start Marketing Date : 2021-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
About the Company : MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&D teams, supported b...
About the Company : Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our em...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
About the Company : Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer of Bulk drugs & Intermediate and also supplies our associate manufacturing plant API / Semi finish form...
About the Company : Hubei Hongzhong Pharmaceutical Co., Ltd. was founded in 2007 and is located in Li Shizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province. The company's products have...
About the Company : Parth Antibiotics Pvt. Ltd. Established in decade ago as a Indenting, Exporting & Trading house with Head Office in Mumbai for Pharmaceutical API, Intermediate, Excipient, Chemical...
About the Company : Established in the year 2004, Sakar is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injec...
About the Company : VINKEM - One Stop Solution for complete range ofOncology In-house API's & Finished dosage injectables in liquid vials andlyophilized form.State of Art cGMP facility with DMF and ...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
ADCETRIS (brentuximab vedotin) is an antibody-drug conjugate (ADC) comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seagen’s proprietary technology.
Lead Product(s): Brentuximab Vedotin,Doxorubicin Hydrochloride,Vincristine Sulfate
Therapeutic Area: Oncology Brand Name: Adcetris
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 11, 2022
Lead Product(s) : Brentuximab Vedotin,Doxorubicin Hydrochloride,Vincristine Sulfate
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Seagen Announces U.S. FDA Approval of New Indication for ADCETRIS® (brentuximab vedotin) for Chil...
Details : ADCETRIS (brentuximab vedotin) is an antibody-drug conjugate (ADC) comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seagen’s proprietary tec...
Brand Name : Adcetris
Molecule Type : Large molecule
Upfront Cash : Not Applicable
November 11, 2022
Details:
The ten year SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) is a Phase III clinical trial designed to evaluate potential treatment pathways for children identified with the disease.
Lead Product(s): Vincristine Sulfate,Carboplatin,Etoposide
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: Undisclosed
Deal Size: $0.7 million Upfront Cash: Undisclosed
Deal Type: Funding May 21, 2020
Lead Product(s) : Vincristine Sulfate,Carboplatin,Etoposide
Therapeutic Area : Oncology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : $0.7 million
Deal Type : Funding
Funding Secured For UK Clinical Trial in Children With Neuroblastoma
Details : The ten year SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) is a Phase III clinical trial designed to evaluate potential treatment pathways for children identified with the disease.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 21, 2020
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 1MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 2MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 5MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VINCRISTINE SULFATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2003-10-28
Application Number : 76401
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VINCRISTINE SULFATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/VIAL
Packaging :
Approval Date : 1988-04-11
Application Number : 71560
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Vincristine Pharmacia
Dosage Form : INJEKTIONSVÄTSKA, LÖSNING
Dosage Strength : 1 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : P&U Vincristine CSV 1mg/1ml Injection
Dosage Form : INJ
Dosage Strength : 1mg/ml
Packaging : 1X5mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VINCASAR PFS
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 1987-07-17
Application Number : 71426
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Vincristine Hospira
Dosage Form : INJEKTIONSVÄTSKA, LÖSNING
Dosage Strength : 1 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Vincristine Hospira
Dosage Form : Injection fluid, resolution
Dosage Strength : 1 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vincristine Hospira
Dosage Form : Injection fluid, resolution
Dosage Strength : 1 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
Brand Name : Vincristine Pharmacia
Dosage Form : INJEKTIONSVÄTSKA, LÖSNING
Dosage Strength : 1 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Vincristine Pfizer
Dosage Form : Inj Solution
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Vincristine Pfizer
Dosage Form : Inj L?s
Dosage Strength : 2mg/2ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Oncovin Liquid
Dosage Form : Inj Solution
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Vincristine
Dosage Form : Vincristine 1Mg 1Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 1 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Vincristine-Teva
Dosage Form : Inj Solution
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Vincristine-Teva
Dosage Form : Inj Solution
Dosage Strength : 2mg/2ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 2MG/2ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 1MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Packaging :
Regulatory Info :
Dosage : Lyophilised Injection
Dosage Strength : 1MG/Vial
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 2MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Packaging :
Regulatory Info :
Dosage : Lyophilised Injection
Dosage Strength : 2MG/Vial
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 5MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Packaging :
Regulatory Info :
Dosage : Lyophilised Injection
Dosage Strength : 5MG/Vial
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : INJECTION
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 1MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG
Packaging : 5 ml + WFI
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 5 ml + WFI
Regulatory Info :
Dosage : Injection
Dosage Strength : 5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : VINTHER
Dosage Form : Injection
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1mg
Brand Name : VINTHER
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : VINTHER
Dosage Form : Injection
Dosage Strength : 2mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 2mg
Brand Name : VINTHER
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1MG/1ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?